StockData
Geron Corp logo

Geron Corp (GERN) stock

GERNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 2/30
$0.87−0.04 (-4.63%)

Close on Nov 20, 2026Market cap $559.40MP/E –Yield –

Geron shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

Geron's shares outstanding was 1M at Jun 30, 2026. For fiscal 2025 it was 667M, up 3.2% from the year before. Over ten years it grew 15.1% a year on average. The highest annual figure on record is 667M in fiscal 2025.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 2025667M+3.2%
FY2024Dec 31, 2024646M+13.2%
FY2023Dec 31, 2023571M+49.9%
FY2022Dec 31, 2022381M+16.2%
FY2021Dec 31, 2021328M+20.7%
FY2020Dec 31, 2020271M+42.8%
FY2019Dec 31, 2019190M+7.7%
FY2018Dec 31, 2018177M+10.9%
FY2017Dec 31, 2017159M+0.1%
FY2016Dec 31, 2016159M-2.2%
FY2015Dec 31, 2015163M+5.9%
FY2014Dec 31, 2014154M+19.6%
FY2013Dec 31, 2013128M+1.1%
FY2012Dec 31, 2012127M+2.0%
FY2011Dec 31, 2011125M+27.6%
FY2010Dec 31, 201098M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 20261M+0.7%
Q1 FY2026Mar 31, 20261M+0.5%
Q4 FY2025Dec 31, 2025667M+0.5%
Q3 FY2025Sep 30, 2025667M+0.7%
Q2 FY2025Jun 30, 20251M-99.9%
Q1 FY2025Mar 31, 20251M-99.9%
Q4 FY2024Dec 31, 2024664M+11.6%
Q3 FY2024Sep 30, 2024662M+14.3%
Q2 FY2024Jun 30, 2024654M+19.5%
Q1 FY2024Mar 31, 2024603M+10.8%
Q4 FY2023Dec 31, 2023595M+56.2%
Q3 FY2023Sep 30, 2023580M+43.0%
Q2 FY2023Jun 30, 2023547M+35.5%
Q1 FY2023Mar 31, 2023544M+64.0%
Q4 FY2022Dec 31, 2022381M+15.2%
Q3 FY2022Sep 30, 2022405M+23.2%
Q2 FY2022Jun 30, 2022404M+23.5%
Q1 FY2022Mar 31, 2022332M+2.6%
Q4 FY2021Dec 31, 2021331M+3.7%
Q3 FY2021Sep 30, 2021329M+3.2%
Q2 FY2021Jun 30, 2021327M+32.4%
Q1 FY2021Mar 31, 2021324M+61.6%
Q4 FY2020Dec 31, 2020319M+60.8%
Q3 FY2020Sep 30, 2020319M+68.6%
Q2 FY2020Jun 30, 2020247M+32.4%
Q1 FY2020Mar 31, 2020200M+7.4%
Q4 FY2019Dec 31, 2019199M+6.5%
Q3 FY2019Sep 30, 2019189M+2.6%
Q2 FY2019Jun 30, 2019187M+6.9%
Q1 FY2019Mar 31, 2019186M+16.1%
Q4 FY2018Dec 31, 2018186M+17.0%
Q3 FY2018Sep 30, 2018184M+15.8%
Q2 FY2018Jun 30, 2018174M+9.6%
Q1 FY2018Mar 31, 2018161M+0.9%
Q4 FY2017Dec 31, 2017159M+0.1%
Q3 FY2017Sep 30, 2017159M+0.0%
Q2 FY2017Jun 30, 2017159M–
Q1 FY2017Mar 31, 2017159M–
Q4 FY2016Dec 31, 2016159M–
Q3 FY2016Sep 30, 2016159M–

More Geron figures

See a number that looks wrong?